Lexicon Pharmaceuticals | EFFECT: Others
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Artal International S.C.A.
Lexicon Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Artal International S.C.A.(48.4%),Artal International Management S.A.(48.4%), etc.
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Swain Judith L
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sullivan Diane E.
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LEFKOWITZ ROBERT J MD
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SOBECKI CHRISTOPHER J
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEBBANE RAYMOND
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Amouyal Philippe
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BARKER SAM L
Lexicon Pharmaceuticals | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Lexicon Pharmaceuticals | 8-K: Current report
Lexicon Pharmaceuticals | 10-Q: Quarterly report
Lexicon Pharmaceuticals | 8-K: LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SOBECKI CHRISTOPHER J
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Swain Judith L
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LEFKOWITZ ROBERT J MD
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BARKER SAM L
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEBBANE RAYMOND
Lexicon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Amouyal Philippe
No Data